Sulforaphane protects rabbit corneas against oxidative stress injury in keratoconus through activation of the Nrf-2/HO-1 antioxidant pathway

Liu,Ruixing; Yan,Xiaoming

doi:10.3892/ijmm.2018.3820

Sulforaphane protects rabbit corneas against oxidative stress injury in keratoconus through activation of the Nrf-2/HO-1 antioxidant pathway

Authors:
- Ruixing Liu
- Xiaoming Yan
View Affiliations

Affiliations: Department of Ophthalmology, The First Hospital of Peking University, Beijing 100034, P.R. China
Published online on: August 10, 2018 https://doi.org/10.3892/ijmm.2018.3820
Pages: 2315-2328
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to examine whether activation of the nuclear factor E2‑related factor 2 (Nrf‑2)/heme oxygenase‑1 (HO‑1) antioxidant pathway in the cornea was involved in the protective effect of sulforaphane (SF) following keratoconus (KC) injury. Following epithelial debridement, collagenase type II was applied in KC groups at room temperature for 30 min. Following this, rabbits were administered with a subconjunctival (s.c.) injection of SF or placebo (maize oil) daily for a total of 2 weeks. To investigate whether HO‑1 was involved in the Nrf‑2‑related antioxidant pathway, rabbits were injected with zinc (II) protoporphyrin IX (ZnPP IX, s.c.) treatment in combination with SF 24 h following the application of collagenase type II. The protective effects of SF were evaluated by examining the mean keratometry (Km) and central cornea thickness (CCT), measuring reactive oxygen species (ROS) production using immunofluorescent staining, and analyzing the protein expression of NADPH oxidase (Nox) family members Nox‑2 and Nox‑4, and Nrf‑2 and HO‑1 using immunohistochemistry and western blot analysis. The mRNA levels of Nox‑2, Nox‑4, Nrf‑2 and HO‑1 were quantitatively detected by reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) analysis. No significant difference in Km or CCT was observed among groups prior to surgery (P=0.700 and P=0.982, respectively). KC induced an apparent increase of ROS generation, and caused a significant increase in Km and a significant decrease in CCT. These changes were neutralized or reversed by SF treatment. Simultaneously, SF treatment decreased the expression of Nox‑2 and Nox‑4, and enhanced the expression of Nrf‑2 and HO‑1 in the KC corneas. The RT‑qPCR results indicated that SF induced downregulation of the mRNA expression of Nox‑2 and Nox‑4, and upregulation of the mRNA expression of Nrf‑2 and HO‑1 following KC injury. The HO‑1 inhibitor, ZnPP IX, counteracted the protective effects of SF on KC corneas. Therefore, the present study provided evidence that activation of the Nrf‑2/HO‑1 signal transduction pathway may partially promote the protective effect of the antioxidant SF in the KC cornea.

View Figures

View References

1	Rabinowitz YS: Keratoconus. Surv Ophthalmol. 42:297–319. 1998. View Article : Google Scholar : PubMed/NCBI
2	Katsoulos C, Karageorgiadis L, Vasileiou N, Mousafeiropoulos T and Asimellis G: Customized hydrogel contact lenses for kera-toconus incorporating correction for vertical coma aberration. Ophthalmic Physiol Opt. 29:321–329. 2009. View Article : Google Scholar : PubMed/NCBI
3	Abu-Amero KK, Al-Muammar AM and Kondkar AA: Genetics of keratoconus: Where do we stand? J Ophthalmol. 2014:6417082014.PubMed/NCBI
4	Nielsen K, Hjortdal J, Pihlmann M and Corydon TJ: Update on the keratoconus genetics. Acta Ophthalmol. 91:106–113. 2013. View Article : Google Scholar
5	Kenney MC, Chwa M, Atilano SR, Tran A, Carballo M, Saghizadeh M, Vasiliou V, Adachi W and Brown DJ: Increased levels of catalase and cathepsin V/l2 but decreased TIMP-1 in keratoconus corneas: Evidence that oxidative stress plays a role in this disorder. Investig Ophthalmol Vis Sci. 46:823–832. 2005. View Article : Google Scholar
6	Chwa M, Atilano SR, Hertzog D, Zheng H, Langberg J, Kim DW and Kenney MC: Hypersensitive response to oxidative stress in keratoconus corneal fibroblasts. Investig Ophthalmol Vis Sci. 49:4361–4369. 2008. View Article : Google Scholar
7	Buddi R, Lin B, Atilano SR, Zorapapel NC, Kenney MC and Brown DJ: Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem. 50:341–351. 2002. View Article : Google Scholar : PubMed/NCBI
8	Chwa M, Atilano SR, Reddy V, Jordan N, Kim DW and Kenney MC: Increased stress-induced generation of reactive oxygen species and apoptosis in human keratoconus fibroblasts. Investig Ophthalmol Vis Sci. 47:1902–1910. 2006. View Article : Google Scholar
9	Jeong WS, Jun M and Kong AN: Nrf2: A potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal. 8:99–106. 2006. View Article : Google Scholar : PubMed/NCBI
10	Siow RC, Ishii T and Mann GE: Modulation of antioxidant gene expression by 4-hydroxynonenal: Atheroprotective role of the Nrf2/ARE transcription pathway. Redox Rep. 12:11–15. 2007. View Article : Google Scholar : PubMed/NCBI
11	Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, et al: An Nrf2/small maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 236:313–322. 1997. View Article : Google Scholar : PubMed/NCBI
12	Cheng X, Siow RCM and Mann GE: Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: A role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway. Antioxid Redox Signal. 14:469–487. 2011. View Article : Google Scholar
13	Zhang Y, Talalay P, Cho CG and Posner GH: A major inducer of anticarcinogenic protective enzymes from broccoli: Isolation and elucidation of structure. Proc Natl Acad Sci USA. 89:2399–2403. 1992. View Article : Google Scholar : PubMed/NCBI
14	Zhao J, Kobori N, Aronowski J and Dash PK: Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci Lett. 393:108–112. 2006. View Article : Google Scholar
15	Danilov CA, Chandrasekaran K, Racz J, Soane L, Zielke C and Fiskum G: Sulforaphane protects astrocytes against oxidative stress and delayed death caused by oxygen and glucose deprivation. Glia. 57:645–656. 2009. View Article : Google Scholar :
16	Tarozzi A, Morroni F, Merlicco A, Hrelia S, Angeloni C, Cantelli-Forti G and Hrelia P: Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line. J Neurochem. 111:1161–1171. 2009. View Article : Google Scholar : PubMed/NCBI
17	Piao CS, Gao S, Lee GH, Kim DS, Park BH, Chae SW, Chae HJ and Kim SH: Sulforaphane protects ischemic injury of hearts through antioxidant pathway and mitochondrial K(ATP) channels. Pharmacol Res. 61:342–348. 2010. View Article : Google Scholar
18	Cheung IMY, Mcghee CN and Sherwin T: Beneficial effect of the antioxidant riboflavin on gene expression of extracellular matrix elements, antioxidants and oxidases in keratoconic stromal cells. Clin Exp Optom. 97:349–355. 2014.PubMed/NCBI
19	Clark JE, Foresti R, Green CJ and Motterlini R: Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem J. 348(Pt 3): 615–619. 2000. View Article : Google Scholar : PubMed/NCBI
20	Qiao J, Li H, Tang Y, Song W, Rong B, Yang S, Wu Y and Yan X: A rabbit model of corneal Ectasia generated by treatment with collagenase type II. BMC Ophthalmol. 18:942018. View Article : Google Scholar : PubMed/NCBI
21	Zheng H, Whitman SA, Wu W, Wondrak GT, Wong PK, Fang D and Zhang DD: Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy. Diabetes. 60:3055–3066. 2011. View Article : Google Scholar : PubMed/NCBI
22	Park J, Kang JW and Lee SM: Activation of the cholinergic anti-inflammatory pathway by nicotine attenuates hepatic ischemia/reperfusion injury via heme oxygenase-1 induction. Eur J Pharmacol. 707:61–70. 2013. View Article : Google Scholar : PubMed/NCBI
23	Wang W, Wang F, Shi L, Jia X and Lin L: Role of heme oxygenase-1/carbon monoxide system in pulmonary ischemia-reperfusion injury. Interact Cardiovasc Thorac Surg. 9:159–162. 2009. View Article : Google Scholar : PubMed/NCBI
24	He M, Pan H, Xiao C and Pu M: Roles for redox signaling by NADPH oxidase in hyperglycemia-induced heme oxygenase-1 expression in the diabetic retina. Investig Opthalmology Vis Sci. 54:4092–4101. 2013. View Article : Google Scholar
25	Fleige S, Walf V, Huch S, Prgomet C, Sehm J and Pfaffl MW: Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR. Biotechnol Lett. 28:1601–1613. 2006. View Article : Google Scholar : PubMed/NCBI
26	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
27	O'Brien WJ, Heimann T and Rizvi F: NADPH oxidase expression and production of superoxide by human corneal stromal cells. Mol Vis. 15:2535–2543. 2009.PubMed/NCBI
28	Kermer P, Ankerhold R, Klöcker N, Krajewski S, Reed JC and Bähr M: Caspase-9: Involvement in secondary death of axotomized rat retinal ganglion cells in vivo. Brain Res Mol Brain Res. 85:144–150. 2000. View Article : Google Scholar
29	Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD and Yamamoto M: Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the aminoterminal Neh2 domain. Genes Dev. 13:76–86. 1999. View Article : Google Scholar : PubMed/NCBI
30	Hong CW, Sinha-Roy A, Schoenfield L, Mcmahon JT and Dupps WJ Jr: Collagenase-mediated tissue modeling of corneal ectasia and collagen cross-linking treatments. Investig Ophthalmol Vis Sci. 53:2321–2327. 2012. View Article : Google Scholar
31	Wang X, Huang Y, Jastaneiah S, Majumdar S, Kang JU, Yiu SC, Stark W and Elisseeff JH: Protective effects of soluble collagen during ultraviolet-A crosslinking on enzyme-mediated corneal ectatic models. PLoS One. 10:e01369992015. View Article : Google Scholar : PubMed/NCBI
32	Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2:161–174. 2002. View Article : Google Scholar : PubMed/NCBI
33	Davidson AE, Hayes S, Hardcastle AJ and Tuft SJ: The pathogenesis of keratoconus. Eye (Lond). 28:189–195. 2014. View Article : Google Scholar
34	Meek KM and Knupp C: Corneal structure and transparency. Prog Retin Eye Res. 49:1–16. 2015. View Article : Google Scholar : PubMed/NCBI
35	Elsheikh A, Ross S, Alhasso D and Rama P: Numerical study of the effect of corneal layered structure on ocular biomechanics. Curr Eye Res. 34:26–35. 2009. View Article : Google Scholar : PubMed/NCBI
36	Jester JV, Moller-Pedersen T, Huang J, Sax CM, Kays WT, Cavangh HD, Petroll WM and Piatigorsky J: The cellular basis of corneal transparency: Evidence for 'corneal crystallins'. J Cell Sci. 112:613–622. 1999.PubMed/NCBI
37	Karamichos D, Hutcheon a EK, Rich CB, Trinkaus-Randall V, Asara JM and Zieske JD: In vitro model suggests oxidative stress involved in keratoconus disease. Sci Rep. 4:46082014. View Article : Google Scholar : PubMed/NCBI
38	Arnal E, Peris-Martínez C, Menezo JL, Johnsen-Soriano S and Romero FJ: Oxidative stress in keratoconus? Invest Ophthalmol Vis Sci. 52:8592–8597. 2011. View Article : Google Scholar : PubMed/NCBI
39	Gondhowiardjo TD and van Haeringen NJ: Corneal aldehyde dehydrogenase, glutathione reductase, and glutathione S-transferase in pathologic corneas. Cornea. 12:310–314. 1993. View Article : Google Scholar : PubMed/NCBI
40	McKay TB, Sarker-Nag A, Lyon D, Asara JM and Karamichos D: Quercetin modulates keratoconus metabolism in vitro. Cell Biochem Funct. 33:341–350. 2015. View Article : Google Scholar : PubMed/NCBI
41	McKay TB, Lyon D, Sarker-Nag A, Priyadarsini S, Asara JM and Karamichos D: Quercetin attenuates lactate production and extracellular matrix secretion in keratoconus. Sci Rep. 5:90032015. View Article : Google Scholar : PubMed/NCBI
42	Fahey JW, Holtzclaw WD, Wehage SL, Wade KL, Stephenson KK and Talalay P: Sulforaphane bioavailability from glucoraphanin-rich broccoli: Control by active endogenous myrosinase. PLoS One. 10:e01409632015. View Article : Google Scholar : PubMed/NCBI
43	Zhao HD, Zhang F, Shen G, Li YB, Li YH, Jing HR, Ma LF, Yao JH and Tian XF: Sulforaphane protects liver injury induced by intestinal ischemia reperfusion through Nrf2-ARE pathway. World J Gastroenterol. 16:3002–3010. 2010. View Article : Google Scholar : PubMed/NCBI
44	Ping Z, Liu W, Kang Z, Cai J, Wang Q, Cheng N, Wang S, Wang S, Zhang JH and Sun X: Sulforaphane protects brains against hypoxic-ischemic injury through induction of Nrf2-dependent phase 2 enzyme. Brain Res. 1343:178–185. 2010. View Article : Google Scholar : PubMed/NCBI
45	Yoon HY, Kang NI, Lee HK, Jang KY, Park JW and Park BH: Sulforaphane protects kidneys against ischemia-reperfusion injury through induction of the Nrf2-dependent phase 2 enzyme. Biochem Pharmacol. 75:2214–2223. 2008. View Article : Google Scholar : PubMed/NCBI
46	Ziaei A, Schmedt T, Chen Y and Jurkunas UV: Sulforaphane decreases endothelial cell apoptosis in Fuchs endothelial corneal dystrophy: A novel treatment. Investig Ophthalmol Vis Sci. 54:6724–6734. 2013. View Article : Google Scholar
47	Tanito M, Masutani H, Kim YC, Nishikawa M, Ohira A and Yodoi J: Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates retinal light damage in mice. Investig Ophthalmol Vis Sci. 46:979–987. 2005. View Article : Google Scholar
48	Kong L, Tanito M, Huang Z, Li F, Zhou X, Zaharia A, Yodoi J, McGinnis JF and Cao W: Delay of photoreceptor degeneration in tubby mouse by sulforaphane. J Neurochem. 101:1041–1052. 2007. View Article : Google Scholar : PubMed/NCBI
49	Lambeth JD: NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol. 4:181–189. 2004. View Article : Google Scholar : PubMed/NCBI
50	Kensler TW, Wakabayashi N and Biswal S: Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 47:89–116. 2007. View Article : Google Scholar
51	Kobayashi M and Yamamoto M: Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal. 7:385–394. 2005. View Article : Google Scholar : PubMed/NCBI
52	Kang KW, Lee SJ and Kim SG: Molecular mechanism of nrf2 activation by oxidative stress. Antioxid Redox Signal. 7:1664–1673. 2005. View Article : Google Scholar : PubMed/NCBI
53	Ishii T, Itoh K, Ruiz E, Leake DS, Unoki H, Yamamoto M and Mann GE: Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: Activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res. 94:609–616. 2004. View Article : Google Scholar : PubMed/NCBI
54	Wakabayashi N, Slocum SL, Skoko JJ, Shin S and Kensler TW: When NRF2 talks, who's listening? Antioxid Redox Signal. 13:1649–1663. 2010. View Article : Google Scholar : PubMed/NCBI
55	Ryter SW, Alam J and Choi AMK: Heme oxygenase-1/carbon monoxide : From basic science to therapeutic applications. Physiol Rev. 86:583–650. 2006. View Article : Google Scholar : PubMed/NCBI
56	Hu C, Eggler AL, Mesecar AD and Van Breemen RB: Modification of Keap1 cysteine residues by sulforaphane. Chem Res Toxicol. 24:515–521. 2011. View Article : Google Scholar : PubMed/NCBI
57	Kizilgun M, Poyrazoglu Y, Oztas Y, Yaman H, Cakir E, Cayci T, Akgul OE, Kurt YG, Yaren H, Kunak ZI, et al: Beneficial effects of N-acetylcysteine and ebselen on renal ischemia/reperfusion injury. Ren Fail. 33:512–517. 2011. View Article : Google Scholar : PubMed/NCBI
58	Rosani U, Tarricone E, Venier P and Brun P, Deligianni V, Zuin M, Martines E, Leonardi A and Brun P: Atmospheric-pressure cold plasma induces transcriptional changes in ex vivo human corneas. PLoS One. 10:e01331732015. View Article : Google Scholar : PubMed/NCBI
59	Yalçin E, Altin F, Cinhüseyinoglue F and Arslan MO: N-acetylcysteine in chronic blepharitis. Cornea. 21:164–168. 2002. View Article : Google Scholar
60	Schmidl D, Werkmeister R, Kaya S, Unterhuber A, Witkowska KJ, Baumgartner R, Höller S, O'Rourke M, Peterson W, Wolter A, et al: A controlled, randomized double-blind study to evaluate the safety and efficacy of chitosan-N-acetylcysteine for the treatment of dry eye syndrome. J Ocul Pharmacol Ther. 33:375–382. 2017. View Article : Google Scholar : PubMed/NCBI
61	Ishii T, Miyazawa M, Onouchi H, Yasuda K, Hartman PS and Ishii N: Model animals for the study of oxidative stress from complex II. Biochim Biophys Acta. 1827:588–597. 2013. View Article : Google Scholar